CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q1 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,631,305 | -13.0% | 57,427 | -8.0% | 0.00% | -20.0% |
Q3 2022 | $3,023,000 | +230.4% | 62,403 | +58.5% | 0.01% | +400.0% |
Q1 2021 | $915,000 | +281.2% | 39,373 | +253.8% | 0.00% | – |
Q3 2020 | $240,000 | +361.5% | 11,128 | +75.5% | 0.00% | – |
Q4 2017 | $52,000 | – | 6,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |